← Evidence map

ArticleCancer cell international2021

CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinoma.

Tao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33602237